All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| STXS / Stereotaxis, Inc.
|
|
|
|
|
|
|
|
| EPIX / ESSA Pharma Inc.
|
|
|
|
|
|
|
|
| NERV / Minerva Neurosciences, Inc.
|
|
|
|
|
|
|
|
| SLS / SELLAS Life Sciences Group, Inc.
|
|
|
|
|
|
|
|
| IBB / iShares Trust - iShares Biotechnology ETF
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| NDRM / NeuroDerm Ltd.
|
|
|
|
|
|
|
|
| US46333XAD03 / Ironwood Pharmaceuticals, Inc. DBCV 2.250% 6/1
|
|
|
|
|
|
|
|
| ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
| AGTC / Applied Genetic Technologies Corp
|
|
|
|
|
|
|
|
| SRRA / Sierra Oncology Inc
|
|
|
|
|
|
|
|
| BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| RDUS / Radius Recycling, Inc.
|
|
|
|
|
|
|
|
| BLCM / Bellicum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ADXS / Ayala Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| JNJ / Johnson & Johnson
|
|
|
|
|
|
|
|
| ABEO / Abeona Therapeutics Inc.
|
|
|
|
|
|
|
|
| TMBR / Timber Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| ALDR / Alder BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| 74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
|
|
|
|
|
|
|
|
| EXAC / Exactech, Inc.
|
|
|
|
|
|
|
|
| NXTM / NxStage Medical, Inc.
|
|
|
|
|
|
|
|
| NVDQ / ETF Opportunities Trust - T-Rex 2X Inverse NVIDIA Daily Target ETF
|
|
|
|
|
|
|
|
| ELOS / Syneron Medical Ltd.
|
|
|
|
|
|
|
|
| DSCI / Derma Sciences, Inc.
|
|
|
|
|
|
|
|
| EIGR / Eiger BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| 45784PAD3 / Insulet Corp. Bond
|
|
|
|
|
|
|
|
| 45780VAB8 / Inotek Pharmaceuticals Corporation Bonds 5.75% 8/1/2021
|
|
|
|
|
|
|
|
| ARQL / ArQule, Inc.
|
|
|
|
|
|
|
|
| CNCE / Concert Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| OBSV / ObsEva SA.
|
|
|
|
|
|
|
|
| GEMP / Gemphire Therapeutics Inc.
|
|
|
|
|
|
|
|
| ANAB / AnaptysBio, Inc.
|
|
|
|
|
|
|
|
| GNVC / GenVec, Inc.
|
|
|
|
|
|
|
|
| US64052L1061 / Neos Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TSRO / TESARO, Inc.
|
|
|
|
|
|
|
|
| FOMX / Foamix Pharmaceuticals Ltd.
|
|
|
|
|
|
|
|
| US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| VSCI /
|
|
|
|
|
|
|
|
| LOXO / Loxo Oncology, Inc.
|
|
|
|
|
|
|
|
| CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| / Immunomedics, Inc.
|
|
|
|
|
|
|
|
| SGYPQ / SYNERGY PHARMACEUTICALS INC DEL
|
|
|
|
|
|
|
|
| US0906721065 / BioTelemetry, Inc.
|
|
|
|
|
|
|
|
| SPNC / Spectranetics Corp. (The)
|
|
|
|
|
|
|
|
| DERM / Journey Medical Corporation
|
|
|
|
|
|
|
|
| CHEK / Check-Cap Ltd.
|
|
|
|
|
|
|
|
| CYAD / Celyad Oncology - ADR
|
|
|
|
|
|
|
|
| ADMP / Adamis Pharmaceuticals Corp
|
|
|
|
|
|
|
|
| ABUS / Arbutus Biopharma Corporation
|
|
|
|
|
|
|
|
| TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
|
|
|
|
|
|
| CASC / Cascadian Therapeutics, Inc.
|
|
|
|
|
|
|
|
| PIRS / Pieris Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| AERI / Aerie Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| AGLE / Aeglea BioTherapeutics Inc
|
|
|
|
|
|
|
|
| VYGR / Voyager Therapeutics, Inc.
|
|
|
|
|
|
|
|
| XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| AFMD / Affimed N.V.
|
|
|
|
|
|
|
|
| BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
| CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
| FSTX / F-star Therapeutics Inc
|
|
|
|
|
|
|
|
| AKBA / Akebia Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SCYX / SCYNEXIS, Inc.
|
|
|
|
|
|
|
|
| ARDX / Ardelyx, Inc.
|
|
|
|
|
|
|
|
| PODD / Insulet Corporation
|
|
|
|
|
|
|
|
| ATRC / AtriCure, Inc.
|
|
|
|
|
|
|
|
| CARA / Cara Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
| QURE / uniQure N.V.
|
|
|
|
|
|
|
|
| BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| AVGR / Avinger, Inc.
|
|
|
|
|
|
|
|
| NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
| MGNX / MacroGenics, Inc.
|
|
|
|
|
|
|
|
| CBAY / CymaBay Therapeutics, Inc.
|
|
|
|
|
|
|
|
| PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VIRX / Viracta Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CDTX / Cidara Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MASI / Masimo Corporation
|
|
|
|
|
|
|
|
| AXSM / Axsome Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TNDM / Tandem Diabetes Care, Inc.
|
|
|
|
|
|
|
|
